Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial - Beelen, Dietrich W.; Trenschel, Rudolf; Stelljes, Matthias; Groth, Christoph; Masszi, Tamás; Reményi, Péter; Wagner-Drouet, Eva; Hauptrock, Beate; Dreger, Peter; Luft, Thomas; Bethge, Wolfgang; Vogel, Wichard; et al. (The lancet. Haematology, 2020)
Published Online October 9, 2019